Scripps-led consortium wins $129M grant for HIV vaccine research

An international research group led by investigators at San Diego-based Scripps Research received a $129 million grant to advance the development of an HIV vaccine.

Four things to know:

1. The Scripps Consortium for HIV/AIDS Vaccine Development received the seven-year grant from the National Institutes of Health.

2. The consortium's 26 researchers will use the funding to advance HIV vaccine candidates to early stage clinical trials. 

3. The research will occur at 14 affiliated institutions, including Scripps Research.

4. The experimental vaccines, designed to be administered in several stages, have demonstrated long-lasting protection against several HIV strains in animal studies.

More articles on clinical leadership and infection control:
Viewpoint: Antibiotic resistance should not make us feel helpless
Trends in nurse leaders' salary and compensation: 5 report findings
Florida practice contacts police after mom films daughter licking medical supplies

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


IC Database-3

Top 40 Articles from the Past 6 Months